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Abstract
This review summarises key research papers in the fields of
cardiology and intensive care published during 2007 in Critical
Care. To create a context and for comparison with the papers
described in the review, we cite studies on the same subject
published in other journals. The papers have been grouped into
four categories: venous oximetry, cardiac surgery, perioperative
fluid optimisation, and haemodynamic monitoring.
Venous oximetry
Mixed venous oxygen saturation (SvO2) and central venous
oxygen saturation (ScvO2) – measured from the superior
vena cava (SVC) – are used as indicators of adequacy of
oxygen supply to the tissues. However, obtaining SvO2
requires the insertion of a pulmonary artery catheter (PAC),
which is invasive and is associated with an increased risk of
complications [1]. ScvO2 has been used as a surrogate for
SvO2, and targeting ScvO2 in the treatment of patients with
severe sepsis is associated with a significant survival benefit
[2]. For this reason, the measurement of ScvO2 is now part of
the 6-hour sepsis bundle and is recommended by the
Surviving Sepsis Campaign guidelines [3]. However, some
questions remain: Is ScvO2 an accurate reflection of SvO2?
How well do they correlate? What is the mechanism
accounting for the observed differences between the two
parameters [4-8]?
Generally, ScvO2 is approximately 3% to 5% higher than
SvO2 as oxygen saturation (SO2) decreases as blood travels
from the SVC to the pulmonary artery (PA). The gradient
varies considerably among individuals, depending on the
particular disease state and on the value of SvO2 [9]. The
gradient in SO2 and lactate [Lac] between SVC and PA
(ΔSO2 and Δ[Lac], respectively) may develop as blood from
the SVC mixes with blood draining from the inferior vena cava
(IVC) and/or from the heart’s venous system [6].
To test this hypothesis, Gutierrez and colleagues [10]
conducted a prospective observational study in nine haemo-
dynamically stable adults without intracardiac defects or
significant valvular disease who underwent right heart
catheterisation for mild-to-moderate pulmonary hypertension.
The authors found a significant mean ΔSO2 of 4.4% and a
Δ[Lac] of 0.16 mmol/L. The lower values in SO2 and [Lac]
measured in the PA could not be explained by the mixing of
blood from the IVC with blood from the SVC, as
hypothesised, since SO2 and [Lac] were similar in the IVC
and SVC. The fact that the greatest decrease in SO2 and
[Lac] occurred in the right atrium (location of the coronary
sinus and the Thebesian venous system) suggests that the
ΔSO2 and Δ[Lac] are due to the mixing of SVC/IVC blood
with the coronary venous blood. This finding is relevant not
only because it can explain the ΔSO2 and Δ[Lac] seen in
these patients but also because, as SO2 and [Lac] in the
coronary venous blood vary in proportion to their rates of
utilisation by the heart, it is conceivable that ΔSO2 and Δ[Lac]
may serve as markers of myocardial metabolism.
A low ScvO2 has been associated with an increased risk of
postoperative complications in high-risk surgery [11] and in
severe sepsis [2]. However, the ScvO2 profile of other
groups of patients is unknown. Bracht and colleagues [12]
showed that a low ScvO2 (<60%) at admission to the
intensive care unit (ICU) was associated with increased
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mortality in an unselected group of 98 unplanned ICU
admissions but that it did not impact on the ICU or hospital
length of stay. Values of ScvO2 in this study were not used to
guide haemodynamic management. The mean ScvO2 values
were 70% at ICU admission and 71% six hours later. There
was no overall change in ScvO2 from baseline to six hours
later in either the surviving or nonsurviving patients. However,
there was a significant increase, but not normalisation, in
ScvO2 at six hours in the group of patients with a baseline
ScvO2 value of less than 60% (52% to 63%). Changes in
ScvO2 were not predictive of mortality or length of stay.
Receiver operating characteristic (ROC) curve analysis
revealed that, while two optimal cutoff values for the
association of ScvO2 with 28-day mortality could be
demonstrated (60% and 69%), only patients with an ScvO2
of 60% or less had a higher 28-day mortality compared with
patients with an ScvO2 of greater than 60% (29% versus
17%). This cutoff point may have been useful in showing an
association between low ScvO2 and mortality but, in view of
the poor sensitivity and overall area under the ROC curve
(0.53), should not guide therapy or interventions. The
relationship between ScvO2, lactate, and cardiac output
(CO) was not addressed, as these last two parameters were
not measured.
It is also interesting to note that the overall proportion of
patients with an ScvO2 of less than 60% on ICU admission
was 21%. The ScvO2 for the septic group was 68%,
significantly higher than 49%, as reported by Rivers and
colleagues [2]. Similarly, recent data from Dutch ICUs report
that patients with severe sepsis or septic shock had a mean
ScvO2 of 74%. Low values of ScvO2 were uncommon and
only 1% of patients presenting to the ICU had an ScvO2 of
less than 50% [13]. These data raise concerns about the
utility of ScvO2 in sepsis in the ICU as supposed to emer-
gency department and will require further studies [14].
Furthermore, SvO2 and ScvO2, though used as indirect
indices of global tissue oxygenation, do not provide any
insight into the state of oxygen utilisation in tissues [15].
Newer noninvasive methods have been tested as a surrogate
measurement of tissue perfusion.
Podbregar and Mozina [16] investigated the relationship
between SvO2 and skeletal (thenar) muscle tissue
oxygenation (StO2) estimated noninvasively by near infrared
spectroscopy (NIRS) in 65 patients with severe left heart
failure (left ventricular systolic ejection fraction of less than
40% and PA occlusion pressure [PAOP] of greater than
18 mm Hg) with or without severe sepsis. The authors
showed that StO2 was higher in patients with sepsis (90%
versus 84%). In nonseptic patients, there was a good
correlation between StO2 and SvO2 and between SvO2 and
plasma lactate. StO2 and SvO2 tracked well with each other
over time, although StO2 overestimated SvO2 with a bias of -
2.3% and a precision 4.6%. No correlation or agreement was
found between StO2 and SvO2 or between StO2 and lactate
in septic patients. The authors concluded that StO2 would be
able to estimate SvO2 in patients with low CO and preserved
O2 extraction ratio (nonseptic patients), suggesting that in
these circumstances, StO2 and its temporal trends could be
used as a fast, continuous, and noninvasive estimate of SvO2.
However, StO2 is not reliable in septic patients with poor
ventricular function and low O2 extraction ratio. In these
patients, StO2 overestimates the overall oxygen delivery, as
the high StO2/low SvO2 suggest blood flow redistribution,
with a reduction in the oxygen content in the IVC and
reduced cellular oxygen extraction. In the accompanying
editorial, Puyana and Pinsky [15] highlight the complexities of
interpreting StO2 in relation to SvO2 and the fact that the
relationship between StO2 and SvO2 is not always
predictable and may have different temporal kinetics in
different diseases (for example, sepsis and hypovolaemia)
and different stages of the same disease when mitochondrial
dysfunction will impair cellular oxygen extraction.
Cardiac surgery
Cardiac biomarkers may aid the detection of patients at a
higher risk of death or complications following cardiac
surgery. Cardiac troponin I (cTnI) is a highly sensitive and
specific biological marker of myocardial necrosis; it is an
independent predictor of adverse outcome and of ICU and
hospital lengths of stay in patients receiving cardiac surgery
[17,18]. In a prospectively recorded database of patients
who were scheduled for elective coronary artery bypass graft
(CABG), valve replacement, or combined surgery with
cardiopulmonary bypass (CPB) and who were deemed to be
at low risk of death, Fellahi and colleagues [19] showed that
the magnitude of postoperative cTnI release is related to the
type of surgery. The increase in cTnI was greater in complex
and prolonged surgical procedures, even in the absence of
postoperative complications. Postoperative cTnI levels were
higher in combined surgery (11.0 ng/mL) and valve
replacement (7.8 ng/mL) compared with post CABG
(5.2 ng/mL). Values of cTnI of greater than 0.6 ng/mL were
considered abnormal. The study suggests that the levels of
cTnI indicative of myocardial injury depend on the type of
cardiac surgery performed. Thresholds of cTnI predicting
severe cardiac event or death were higher in combined
surgery (11.8 ng/mL) and valve surgery (9.3 ng/mL) com-
pared with CABG (7.8 ng/mL). The specificity and negative
predictive value of cTnI were greater after CABG, suggesting
that an increase in postoperative cTnI after CABG surgery is
more closely related to additional postoperative myocardial
injury and poorer outcome. In this study, of the five variables
significantly associated with severe cardiac event or death
(elevated cTnI above the threshold, a left ventricular ejection
fraction of less than 50%, treatment by diuretics, chronic
obstructive pulmonary disease, and the duration of CPB), an
elevated cTnI above the identified threshold was associated
with the greatest odds of complications or death (odds ratio
of 4.33). However, the authors point out that, as death was a
rare event in the study, the thresholds identified may not
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accurately predict death, which is probably associated with
higher values of cTnI.
Extracorporeal circulation during cardiac surgery induces
haemostatic alterations that lead to an inflammatory response
(IR) and postoperative bleeding secondary to activation of the
coagulation-fibrinolytic cascades. Jimenez and colleagues
[20] show, in a case-control study on 165 patients under-
going elective CPB, that the 20.6% of patients who
developed an IR had a longer lengths of stay in the ICU (7.8
versus 3.2 days) and in the hospital (17.6 versus 9.1 days).
Of the patients who developed IR, 64% developed vaso-
plegic shock (VS). The incidence of IR was reduced by the
administration of tranexamic acid (TA) (17% versus 42%),
with an absolute risk reduction of 25% (numbers needed to
treat = 4). Furthermore, the rates of incidence of VS were 0%
in the TA group and 23% in the placebo group. Patients
treated with TA had reduced inflammatory markers and
required lower doses of vasopressors and a shorter duration
of mechanical ventilation. The trial was interrupted early due
to the higher incidence of bleeding in the placebo group.
Perioperative fluid optimisation
Traditional clinical and monitoring parameters tend to under-
estimate the amount of volume required for resuscitation and
haemodynamic optimisation in critically ill patients. Hypo-
volaemia in multiple-trauma patients causes reduced oxygen
delivery to the tissues and an increase in blood lactate and,
even in the presence of normal physiological parameters
(cryptic hypoperfusion), often leads to multiple organ dys-
function [21].
Oesophageal Doppler (OD) is a useful noninvasive tool for
the management of fluid replacement in the perioperative
period and in the ICU. In a randomised unblinded study on
162 multiple-trauma patients conducted in a single centre
experienced with the use of OD, Chytra and colleagues [22]
found that guiding fluid management with OD (aiming for a
corrected flow time of greater than 0.35 seconds and a less
than 10% change in stroke volume after a fluid challenge)
resulted in the administration of a 2.4-fold increase in colloid
in the first 12 hours in the ICU, which achieved a significant
reduction in the mean blood lactate levels at 12 hours (2.92
versus 3.23 mmol/L) and 24 hours (1.99 versus 2.37 mmol/L).
Fewer patients were on vasopressors and the dose of
noradrenaline was lower in the OD group. However, there
was no difference in organ dysfunction. There was also a
significantly lower proportion of patients who developed
infectious complications in the OD group (8.8% versus
34.1%, relative risk of 0.55), which may be a consequence of
better tissue oxygenation and healing. Furthermore, patients
had shorter stays in the ICU (median reduction of 1.5 days)
and in the hospital (median reduction of 3.5 days), but there
was no change in ICU and hospital mortalities. However, the
study was powered to detect only a 0.6 mmol/L difference in
blood lactate and a 2-day reduction in ICU length of stay; it
was not powered to detect a mortality difference between the
two groups. Therefore, the effect of OD-guided fluid manage-
ment on mortality in this study cannot be quantified. Further-
more, OD is time-consuming and requires experienced
operators, and patients need to be deeply sedated to tolerate
the OD probe. The positive results of goal-directed fluid
optimisation reported in the study could potentially also be
achieved with the use of other relatively noninvasive devices
that measure stroke volume, CO, or other derived measures.
In anaesthetised patients without cardiac arrhythmias, the
variation in the arterial pulse pressure (PPV) induced by
mechanical ventilation seems to be a more accurate predictor
of fluid responsiveness than volumetric indices of preload (for
example, CVP). PPV can be useful in determining the
haemodynamic consequences of haemofiltration (that is,
excessive fluid removal) or of positive end-expiratory pressure
before a recruitment manoeuvre or to optimise fluid adminis-
tration in acute respiratory distress syndrome, in which
carefully monitored fluid management can affect lung function
and duration of mechanical ventilation [23]. However, PPV is
valid only if a series of conditions are met: (a) if there is a
reliable arterial trace during normal sinus rhythm, (b) in the
absence of spontaneous breathing, and (c) in the absence of
excessively low tidal volumes. PPV is not an indicator of
volume status or a marker of cardiac preload but is an
indicator of the position of the cardiovascular system on the
Frank-Starling curve. A series of articles published in Critical
Care in 2007 have investigated further possible applications
of PPV: intraoperative fluid optimisation of patients under-
going cardiac surgery or high-risk surgery.
Sander and colleagues [24] evaluated the suitability of
central venous pressure (CVP), PAOP, global end-diastolic
volume index (GEDVI), PPV, and stroke volume variation
(SVV) for predicting changes in the cardiac index (CI) and
stroke volume index (SVI) after sternotomy in cardiac surgery
patients. This study showed that dynamic parameters such as
PPV and SVV are more accurate in predicting changes in CO
following sternotomy than classic static pressure measure-
ment such as CVP and pulmonary capillary wedge pressure
(PCWP). Sternotomy causes a decrease in airway pressures
and hence decreases the effects of mechanical ventilation on
venous return. Because PPV is directly influenced by the
magnitude of cyclic changes in pleural pressure induced by
mechanical ventilation, after sternotomy there was a
significant decrease in PPV and SVV and increase in CI and
SVI as a sole consequence of changes in airway pressure.
However, unlike CVP and PCWP, changes in GEDVI, SVV,
and PPV correlate with changes in CI and therefore appear to
be more reliable under these conditions.
Several studies have shown that monitoring and maximising
stroke volume by fluid loading during high-risk surgery (until
the stroke volume remains unchanged indicating that it has
reached the plateau of the Frank-Starling curve) is associated
Available online http://ccforum.com/content/12/5/232
with improved postoperative outcome. By increasing cardiac
preload, volume loading induces a rightward shift on the
preload/stroke volume relationship and hence a decrease in
PPV. The clinical and intraoperative goal of ‘maximising stroke
volume by volume loading’ can therefore be achieved simply
by minimising PPV with the advantage of being less invasive.
In their paper, Lopes and colleagues [25] show that
minimising PPV (<10%) by volume loading with hydroxyethyl-
starch 6% boluses during high-risk surgery decreases the
proportion of patients developing postoperative complica-
tions (41% versus 75%, 1.4 versus 3.9 complications per
patient), the duration of mechanical ventilation (median
reduction of 4 days), and the lengths of stay in the ICU and
the hospital (median reduction of 6 and 10 days, respec-
tively). Patients in the intervention study received a signifi-
cantly greater amount of fluid (4,618 versus 1,694 mL) and
the PPV decreased from 22% to 9%. Unfortunately, PPV was
not measured in the control group for comparison. At 24 hours,
fewer patients in the treatment group required vasoactive
drugs (12% versus 50%), and the mean blood lactate
concentration over 24 hours was lower than that of controls
(1.2 versus 2.4 mmol/L). The study was stopped after the
interim analysis (33 patients enrolled) because of a significant
decrease in the length of stay in the hospital (primary
endpoint) in the treatment group. These results are in agree-
ment with other fluid optimisation studies in which the use of
more invasive haemodynamic parameters, such as GEDVI in
patients undergoing cardiac surgery, was associated with a
reduced requirement of vasoactive drugs and a shorter
duration of mechanical ventilation and ICU stay [26].
Haemodynamic monitoring
CO can be assessed noninvasively from the analysis of the
arterial pressure waveform. Each commercially available CO
monitor uses a different proprietary algorithm to relate
arterial pressure to stroke volume and thus CO. Some of
these devices require calibration via a bolus dilution
technique, which needs to be repeated at regular intervals or
after a significant change in CO (calibrated systems). Other
devices use algorithms that calculate the stroke volume
based on the characteristics of the arterial waveform and
individual patient demographics, without requiring calibration
(uncalibrated systems).
McGee and colleagues [27], in a multicentre prospective
clinical study on 84 patients, show that arterial pressure-
based CO (APBCO) measurement using a Vigileo monitor/
FloTrac sensor system (Edwards Lifesciences LLC, Irvine CA,
USA) is comparable to the intermittent bolus thermodilution
CO (ICO) technique using PAC and has the additional advan-
tage of being noninvasive. Comparison of APBCO versus
ICO showed a bias of 0.20 L/minute and a precision of
± 1.28 L/minute (limits of agreement of -2.36 to 2.75 L/minute).
When changes in CO were measured by APBCO, 59% of
the time the error in tracking the magnitude and the direction
of the change in CO as measured by ICO was within ± 15%,
96% of the time it was within ± 30%, and 4% of the time it
was greater than 30%. The limits of agreement for the differ-
ence between APBCO and ICO were 43% (significantly
larger than ± 30%), which represent the value suggested for
the limits of agreement between two equivalent methods [28].
Although arterial PPV has primarily been used to assess fluid
volume responsiveness, Keyl and colleagues [29] investi-
gated the effects of changes in cardiac performance/
contractility after biventricular resynchronisation on PPV. The
purpose of the study was to demonstrate that PPV can be
modified by changes in contractility – in the absence of a
significant change in heart rate, vascular tone, or intravascular
volume status – in accordance with the Frank-Starling
mechanism. In 19 patients undergoing the implantation of a
biventricular pacing/defibrillator device for New York Heart
Association class III-IV heart failure and ventricular dys-
synchrony, the authors assessed dynamic blood pressure
regulation during right ventricular and biventricular pacing in
the frequency domain (power spectral analysis) and in the
time domain (PPV is the difference between the maximal and
minimal pulse pressure [PP] values, normalised by the mean
value and expressed as a percentage). Respiratory PPV
increased significantly during cardiac resynchronisation. PPV
variation assessed in the time domain increased 1.3-fold from
a median (interquartile range) of 5.3% (3.1% to 12.3%)
during right ventricular pacing to 6.9% (4.7% to 16.4%) during
biventricular pacing. These results highlight the influence of
cardiac performance on the slope of the preload/stroke
volume relationship. A reduction in ventricular contractility
decreases the slope of the relationship between end-diastolic
volume and stroke volume. Thus, the respiratory fluctuations
of stroke volume and PPV decrease in the failing heart in
mechanically ventilated patients. Conversely, an improvement
in cardiac performance should create an increase in the
respiratory fluctuations of PP. The study suggests that PPV
can be a sensitive parameter of systolic cardiac performance
in mechanically ventilated patients with stable preload and
that this interaction should be considered when interpreting
PPV in ICU patients who receive multiple treatments that can
affect preload as well as contractility. However, the changes
in contractility in this study are assumed from other studies
and indices of contractility (for example, dP/dtmax) are not
reported. Furthermore, in an accompanying editorial, Michard
and colleagues [30] commented that resynchronisation can
lead to changes in left ventricular size and therefore preload,
making the prerequisite of a stable preload assumed in this
study not completely secure [31].
In an attempt to provide an alternative method to quantify
preload noninvasively, Sturgess and colleagues [32], in their
retrospective study of 94 consecutive critically ill patients,
investigated the distribution of tissue Doppler imaging (TDI)
and its correlation with other echocardiographic indices of
preload. The authors found that, in this study population,
Critical Care    Vol 12 No 5 Camporota et al.
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there was a wide range of early diastolic mitral annular
velocity (E′) – a preload-independent index of left ventricular
relaxation – and of the ratio between peak early diastolic
trans-mitral velocity (E) and E′ (E/E′) [33], an estimate of left
ventricular filling pressure that corrects E velocity for the
influence of myocardial relaxation [33,34]. Sixty-seven per-
cent of the patients showed evidence of impaired myocardial
relaxation (E′ of less than 9.6 cm/second) and 15% had an
elevated left ventricular filling pressure (E/E′ of greater than
15). There was no difference between ventilated and
nonventilated patients with regard to the values of E′ and
E/E′. There was a weak correlation between E/E′ and left
atrial area in the mechanically ventilated patients (r = 0.3,
P = 0.026), but no correlations were demonstrated with left
atrial volume, IVC diameter, or left ventricular end-diastolic
volume. In the selected cohort, only an increased left
ventricular end-systolic volume above 105 mL was associated
with excess 28-day mortality. This study shows the complexity
of interpreting tissue Doppler data when there is interplay
between underlying disease and therapeutic strategies
implemented in the ICU. However, it does provide potential
reference ranges for TDI indices in critically ill patients, which
can suggest a framework for planning future studies.
Conclusion
This review summarised key research papers published in the
fields of cardiology and intensive care during 2007 in Critical
Care. The papers reflect a wide range of original studies
published in Critical Care covering aspects of cardiovascular
physiology, intensive care, and perioperative medicine.
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